Classifying Variants of Undetermined Significance in BRCA2
Author Information
Author(s): Rachel Karchin, Mukesh Agarwal, Andrej Sali, Fergus Couch, Mary S. Beattie
Primary Institution: Johns Hopkins University
Hypothesis
Can a computational method produce a probabilistic likelihood ratio predictive of whether a missense variant impairs protein function in BRCA2?
Conclusion
The study presents a new bioinformatics method that can help classify variants of uncertain significance in BRCA2, aiding in cancer risk assessment.
Supporting Evidence
- The method shows significant agreement with classifications provided by Myriad Genetics.
- The approach is less likely to make false positive errors than other bioinformatics methods.
- The study indicates that the protein likelihood ratio can be integrated with medical genetics likelihood ratios.
Takeaway
Scientists created a computer program to help doctors understand if certain genetic changes in a cancer-related gene are harmful or not.
Methodology
A computational method using a support vector machine to predict the impact of missense variants in BRCA2.
Potential Biases
The study may be limited by the reliance on existing genetic classifications and the absence of a gold standard.
Limitations
The method does not account for potential effects on mRNA processing and lacks a gold standard for BRCA VUS prediction.
Participant Demographics
Individuals from high-risk breast/ovarian cancer families.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website